The FMCNA team comprises over 45,000 dedicated employees in North America, all of whom are focused on a singular goal: delivering the highest-quality care to help patients with renal disease live the most fulfilling, rewarding lives possible. Join us and we'll connect you to a career and a community that reward you in every way.
We welcome dialysis patients with excellence in care and open arms every day. Fresenius Medical Services is the division of FMCNA that operates over 1,800 dialysis clinics nationwide, delivering life-changing care to more than 135,000 patients through the collaborative efforts of more than 37,000 passionate caregivers. Providing over 10 million treatments annually, Fresenius Medical Services is the operator of the nation's leading network of dialysis services.
Our team of highly trained Nurses, Patient Care Technicians, Social Workers and Dietitians allow us to provide:
- In-center hemodialysis
- Home peritoneal and hemodialysis
- In-center acute dialysis and plasmapheresis services
In addition, Fresenius Medical Services offers educational treatment options programs, pharmacy services and other critical support services to our patients. Offering a sense of purpose and fulfillment every day, we give help and hope to patients and their families.
This is the innovation of caring. In order to achieve our goal of profoundly improving the lives of each and every patient, our committed professionals must have the latest technology at their fingertips. The Renal Therapies Group of FMCNA designs, manufactures and distributes innovative technology used in the treatment of patients with kidney disease and kidney failure. These include:
- Dialysis machines
- Artificial kidneys
- Bloodlines and solutions
Our manufacturing operations are located in Mexico, Canada and the United States. We also distribute specialty renal pharmaceuticals.
Our two laboratories, located in Rockleigh, New Jersey, and Milpitas, California, deliver comprehensive testing, analysis and reporting with the reliability and personal service required to ensure the best outcomes possible for our patients. This is all made possible by our steadfast resolve and the unwavering approach of our passionate employees, who work with:
- State-of-the-art analytical equipment
- Automated specimen processing
- Advanced reporting applications
Based in New York City, the Renal Research Institute is dedicated to advancing renal therapy options and improving the quality of life for patients through tireless research on advanced clinical technology. Our partnerships with leading research universities, hospitals and patient care facilities across the country enable us to make profound breakthroughs that create life-changing outcomes for patients.
Find the balance between your career ambitions and personal aspirations.
Discover a world of options with Fresenius Travel Nurses, the travel nursing division of Fresenius Medical Care NA. As a dialysis travel nurse, you can explore a leading global organization by working in any of our more than 1,800 dialysis clinics. Wherever you want to go, we have a position available for you–which means you can travel the country providing world-class care and making a difference in patients' lives where you are needed most.
And because we have opportunities in cities from coast to coast, you'll experience exciting new regions earning top pay and broadening your clinical skills by working flexible 13-week assignments–while living in free, private housing.
We call our brand of patient care UltraCare® and it represents our commitment to deliver excellent care to patients through innovative programs, the latest technology and a focus on superior customer service. As part of our travel nursing team, no matter where you are, you will set an outstanding example that others will follow.
Fresenius Vascular Care (FVC) is dedicated to improving the care of vascular patients. By using FVC outpatient vascular centers, clinical staff can monitor patients' vascular care on a more routine basis to help improve the quality of care and reduce hospitalizations and missed dialysis treatment days.
Data suggests that coordinated vascular care achieves a functional arteriovenous fistula in approximately 14 weeks versus 24 weeks if the care is not coordinated. Today there are approximately 25,000 Fresenius Medical Services (FMS) patients dialyzing in locations where they could be using our Vascular Care facilities. However, fewer than 20 percent of these patients receive care at a Fresenius Vascular Care facility. FMCNA employees can help improve patient care by increasing the use of FVC. Our goal is to have FVC care for more than 45 percent of our patients by 2013.
We operate freestanding vascular centers with a dedication to providing dialysis patients with timely, reliable, safe, cost-efficient vascular access care. Our board certified Interventional Radiologists, Interventional Nephrologists and Vascular Surgeons are experts in vascular access and endovascular care, and many are pioneers in their fields. We are committed to improving the standard of care and quality of life of dialysis patients by reducing avoidable hospitalizations, reducing incidents of thrombosis, eliminating unnecessary temporary catheters, and decreasing morbidity. Our goal is that every ESRD patient entering one of our centers will leave with a functioning access.
Fresenius Medical Care continues to offer the latest innovations and best practices in dialysate to the dialysis market by providing citric-based acid concentrates and traditional acetic-based concentrates in liquid and dry formulations as well as bicarbonate concentrates in liquid and dry formulations.
- NaturaLyte® Acid Concentrate
- GranuFlo® Dry Acid Concentrate
- Citrasate® Acid Concentrate
- NaturaLyte® Bicarbonate Concentrate
For more information about concentrates, visit http://www.fmcna-concentrates.com
- Quality Systems and Facility Compliance
- Manufacturing Operations
- Manufacturing Engineering / Process Development
- Strategic Procurement/Materials Management
- Supply Chain
- Continuous Improvement
Fresenius Medical Care manufactures products for patients with chronic renal failure at seven high-tech manufacturing plants in the United States and Mexico. The main products are dialysis machines, dialysis solutions, dialyzers, solutions for peritoneal dialysis and bloodlines. A total of several thousand employees work for Fresenius Medical Care at the production sites.
Fresenius Medical Care manages 45 production operations in 30 countries and includes multiple time zones and languages. Three of these countries and languages are in North America, with production facilities in the United States (Ogden, Utah; Walnut Creek, Calif.; Livingston, Calif.; Irving, Texas; Toledo, Ohio), Canada (Montreal); and Mexico (Reynosa and Guadalajara).
The team of passionate professionals at FMCNA is honored to receive the following recognition and awards:
Here's where you can connect to the latest life-changing news at FMCNA.
Click below to read the latest news on our corporate website:
http://www.fmcna.com/fmcna/News/news.html